Intraoperative radiation therapy proving divisive among oncologists

The oncology community is divided over intraoperative radiation therapy, which as its name suggests is given at the same time as lumpectomy to breast cancer patients. Drug delivery disciples are often experts at improving patient adherence and are aware that most patients don't follow instructions. Even when it comes to traditional radiation (delivered as often as 5 days a week for 7 weeks), one-third of women don't complete the course. So, the convenience of intraoperative radiation therapy should not be overlooked. On the other hand, one study found that patients who received the therapy were more than twice as likely to experience recurrence, though the available data has some flaws. More from FierceMedicalDevices

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.